INVO Fertility, Inc.
corporate_fare Company Profile
INVO Fertility, Inc. (NASDAQ:IVF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 29 items for IVF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-27, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 16 rated 8 or above. Recent SEC coverage for IVF spans 8-K, 10-Q, S-1, DEF 14A.
Recent high-impact activity:
- INVO Fertility Sets 1:4 Reverse Split Effective Oct. 30
- INVO Fertility Draws $3.6M from Alumni Capital Equity Line, Selling 2.1M Shares
- INVO Fertility Q2 Revenue Up 17%, Clinic Platform Turns Profitable
- INVO Fertility Q2 Revenue Up 17%, Clinic Platform Turns Profitable
- Q2 Loss Narrows, Cash Up, But Going Concern Remains Amid Highly Dilutive Equity Line & Debt Terms
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 26,478 shares in IVF as of the October 15, 2026 settlement, a 47.2% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 29, 2026, 34.8% of IVF volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for IVF, detected from its recent SEC filings · based on capital-structure filings through 2026-08-28.
First Drawdown Under Equity Line · Dilution Impact
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →